Estimands, Estimators and Sensitivity Analysis in Clinical Trials Estimands, Estimators and Sensitivity Analysis in Clinical Trials
Chapman & Hall/CRC Biostatistics Series

Estimands, Estimators and Sensitivity Analysis in Clinical Trials

Craig Mallinckrodt and Others
    • $62.99
    • $62.99

Publisher Description

The concepts of estimands, analyses (estimators), and sensitivity are interrelated. Therefore, great need exists for an integrated approach to these topics. This book acts as a practical guide to developing and implementing statistical analysis plans by explaining fundamental concepts using accessible language, providing technical details, real-world examples, and SAS and R code to implement analyses. The updated ICH guideline raises new analytic and cross-functional challenges for statisticians. Gaps between different communities have come to surface, such as between causal inference and clinical trialists, as well as among clinicians, statisticians, and regulators when it comes to communicating decision-making objectives, assumptions, and interpretations of evidence.

This book lays out a path toward bridging some of these gaps. It offers

A common language and unifying framework along with the technical details and practical guidance to help statisticians meet the challenges

A thorough treatment of intercurrent events (ICEs), i.e., postrandomization events that confound interpretation of outcomes and five strategies for ICEs in ICH E9 (R1)

Details on how estimands, integrated into a principled study development process, lay a foundation for coherent specification of trial design, conduct, and analysis needed to overcome the issues caused by ICEs:

A perspective on the role of the intention-to-treat principle

Examples and case studies from various areas

Example code in SAS and R

A connection with causal inference

Implications and methods for analysis of longitudinal trials with missing data

Together, the authors have offered the readers their ample expertise in clinical trial design and analysis, from an industrial and academic perspective.

GENRE
Professional & Technical
RELEASED
2019
December 23
LANGUAGE
EN
English
LENGTH
344
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
20.3
MB
Building Your Career as a Statistician Building Your Career as a Statistician
2023
Analyzing Longitudinal Clinical Trial Data Analyzing Longitudinal Clinical Trial Data
2016
Real-World Evidence in Drug Development and Evaluation Real-World Evidence in Drug Development and Evaluation
2021
Medical Risk Prediction Models Medical Risk Prediction Models
2021
Biomarker Analysis in Clinical Trials with R Biomarker Analysis in Clinical Trials with R
2020
Biosimilar Clinical Development: Scientific Considerations and New Methodologies Biosimilar Clinical Development: Scientific Considerations and New Methodologies
2016
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
2020
Statistical Design, Monitoring, and Analysis of Clinical Trials Statistical Design, Monitoring, and Analysis of Clinical Trials
2021